Novel protective antibody target identified against Crimean-Congo hemorrhagic fever virus

A research team led by the United States Army Medical Research Institute of Infectious Diseases, or USAMRIID, that includes Scott Pegan at the UC Riverside School of Medicine has discovered an important protective antibody target against Crimean-Congo hemorrhagic fever virus, or CCHFV.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup